BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ayesh BM, Abu Shaaban AS, Abed AA. Evaluation of CYP2C9- and VKORC1-based pharmacogenetic algorithm for warfarin dose in Gaza-Palestine. Future Sci OA 2018;4:FSO276. [PMID: 29568565 DOI: 10.4155/fsoa-2017-0112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Aboukaoud M, Israel S, Brautbar C, Eyal S. Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations. Pharm Res 2018;35:211. [PMID: 30225831 DOI: 10.1007/s11095-018-2472-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Tajik F, Wang M, Zhang X, Han J. Evaluation of the impact of body mass index on venous thromboembolism risk factors. PLoS One 2020;15:e0235007. [PMID: 32645000 DOI: 10.1371/journal.pone.0235007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Maghsoudi R, Mirzarezaee M, Sadeghi M, Nadjar-Araabi B. Determining the adjusted initial treatment dose of warfarin anticoagulant medicine using kernel-based support vector regression. Comput Methods Programs Biomed 2021;214:106589. [PMID: 34963093 DOI: 10.1016/j.cmpb.2021.106589] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fereidouni M, Moossavi M, Kazemi T, Nouranihassankiade S, Asghari A. Association between polymorphisms of VKORC1 and CYP2C9 genes with warfarin maintenance dose in a group of warfarin users in Birjand city, Iran. J Cell Biochem 2019;120:9588-93. [PMID: 30525241 DOI: 10.1002/jcb.28235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]